Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14928272 | 0.94 | ALDH1A1 (0.38) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL29512028 | 0.89 | ALDH1A1 (0.41) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL132322 | 0.89 | ALDH1A1 (0.41) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL14446782 | 0.85 | ALDH1A1 (0.48) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL134731 | 0.82 | ALDH1A1 (0.46) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL31142138 | 0.82 | ALDH1A1 (0.46) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL21753767 | 0.80 | ALDH1A1 (0.43) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL10128623 | 0.79 | ACHE (0.39) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL1264238 | 0.79 | ACHE (0.41) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL15607183 | 0.79 | ALDH1A1 (0.42) | TDP1KDM4EMAPTL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130137206-A1 | ORGANIC LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME AND METHOD OF FORMING THE SAME | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2013-05-30 | — | — | US | disclosed |
| US-20110163300-A1 | ORGANIC LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME AND METHOD OF FORMING THE SAME | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110163300-A1 | ORGANIC LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME AND METHOD OF FORMING THE SAME | LEF1, LAGE3, FTO | TDP1 3582/4885KDM4E 499/4885MAPT 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.